Yantai Dongcheng Biochemicals Co Ltd banner
Y

Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675

Watchlist Manager
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Watchlist
Price: 13.37 CNY 1.29% Market Closed
Market Cap: ¥11B

Relative Value

The Relative Value of one Yantai Dongcheng Biochemicals Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 13.37 CNY, Yantai Dongcheng Biochemicals Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Yantai Dongcheng Biochemicals Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Yantai Dongcheng Biochemicals Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
11B CNY 4 66.4 40.1 40.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 690 872.8 -160 127.7 -194 446.1 -192 227.3
US
Abbvie Inc
NYSE:ABBV
403.4B USD 6.8 171.8 16.6 23.6
US
Astria Therapeutics Inc
NASDAQ:ATXS
326.4B USD 462 374.5 -2 631.9 -2 389.6 -2 389.6
US
Amgen Inc
NASDAQ:AMGN
205.6B USD 5.6 26.7 15.2 15.2
US
Gilead Sciences Inc
NASDAQ:GILD
182.9B USD 6.2 21.5 14.6 14.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.9B USD 10.3 31.3 24 25
US
Epizyme Inc
F:EPE
94.1B EUR 2 091 -533.6 -581 -565.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.4B USD 5.7 18.1 13.5 15.4
NL
argenx SE
XBRU:ARGX
43.6B EUR 14.2 33.4 57.1 58.7
AU
CSL Ltd
ASX:CSL
70.2B AUD 3.2 16.5 11.3 14.2
P/E Multiple
Earnings Growth PEG
CN
Y
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Average P/E: 48.2
66.4
36%
1.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 127.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
171.8
89%
1.9
US
Astria Therapeutics Inc
NASDAQ:ATXS
Negative Multiple: -2 631.9 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
26.7
18%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
21.5
14%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.3
17%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
13%
1.4
NL
argenx SE
XBRU:ARGX
33.4
42%
0.8
AU
CSL Ltd
ASX:CSL
16.5
11%
1.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Y
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Average EV/EBITDA: 24.1
40.1
33%
1.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 446.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Astria Therapeutics Inc
NASDAQ:ATXS
Negative Multiple: -2 389.6 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
15.2
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
14.6
18%
0.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
15%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
23%
0.6
NL
argenx SE
XBRU:ARGX
57.1
810%
0.1
AU
CSL Ltd
ASX:CSL
11.3
8%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Y
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Average EV/EBIT: 25.8
40.1
24%
1.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 227.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.6
30%
0.8
US
Astria Therapeutics Inc
NASDAQ:ATXS
Negative Multiple: -2 389.6 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
15.2
2%
7.6
US
Gilead Sciences Inc
NASDAQ:GILD
14.6
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
21%
0.7
NL
argenx SE
XBRU:ARGX
58.7
N/A N/A
AU
CSL Ltd
ASX:CSL
14.2
11%
1.3
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett